These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3975651)

  • 1. Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule.
    Carpenter JT; Peterson L
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):40-2. PubMed ID: 3975651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
    Morgan LR
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results with megestrol acetate in patients with advanced carcinoma of the breast.
    Ansfield FJ; Kallas GJ; Singson JP
    Surg Gynecol Obstet; 1982 Dec; 155(6):888-90. PubMed ID: 7147170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
    Cruz JM; Muss HB; Brockschmidt JK; Evans GW
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):63-7. PubMed ID: 2259928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor level as a predictor of response to megestrol acetate in advanced breast cancer: a retrospective study.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Bacon LD; Rossof AH; Economou SG
    Cancer Treat Rep; 1983; 67(7-8):717-20. PubMed ID: 6871887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
    Buzdar AU; Jones SE; Vogel CL; Wolter J; Plourde P; Webster A
    Cancer; 1997 Feb; 79(4):730-9. PubMed ID: 9024711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
    Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megestrol acetate for the palliation of advanced ovarian carcinoma.
    Geisler HE
    Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
    Benghiat A; Cassidy SA; Davidson HE; Mancero FS; Pickard JG; Tyrrell CJ
    Eur J Surg Oncol; 1986 Mar; 12(1):43-5. PubMed ID: 3956753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
    Tchekmedyian NS; Tait N; Aisner J
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):20-5. PubMed ID: 3798125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of megestrol acetate in the treatment of cancer cachexia.
    Parnes H; Tait N; Aisner J
    Nutrition; 1989; 5(3):206-9. PubMed ID: 2520291
    [No Abstract]   [Full Text] [Related]  

  • 13. Megestrol acetate for treatment of endometriosis.
    Schlaff WD; Dugoff L; Damewood MD; Rock JA
    Obstet Gynecol; 1990 Apr; 75(4):646-8. PubMed ID: 2314784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.
    Buzdar AU; Smith R; Vogel C; Bonomi P; Keller AM; Favis G; Mulagha M; Cooper J
    Cancer; 1996 Jun; 77(12):2503-13. PubMed ID: 8640699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
    Buzdar AU; Jonat W; Howell A; Jones SE; Blomqvist CP; Vogel CL; Eiermann W; Wolter JM; Steinberg M; Webster A; Lee D
    Cancer; 1998 Sep; 83(6):1142-52. PubMed ID: 9740079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.
    Geisler HE
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):20-2. PubMed ID: 3975647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
    Pronzato P; Brema F; Amoroso D; Bertelli G; Conte PF; Martini MC; Pastorino G; Rosso R
    Breast Cancer Res Treat; 1990 Nov; 17(1):51-4. PubMed ID: 2095927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megestrol acetate therapy for advanced breast cancer.
    Gregory EJ; Cohen SC; Oines DW; Mims CH
    J Clin Oncol; 1985 Feb; 3(2):155-60. PubMed ID: 3838187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.
    Bonomi P; Pessis D; Bunting N; Block M; Anderson K; Wolter J; Rossof A; Slayton R; Harris J
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):36-9. PubMed ID: 3975650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral high-dose progestins as treatment for advanced breast cancer.
    Lundgren S; Kvinnsland S; Utaaker E
    Acta Oncol; 1989; 28(6):811-6. PubMed ID: 2532917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.